ISUOG/ESGO Consensus Statement on ultrasound‐guided biopsy in gynecological oncology
Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 517-535, April 2025.ABSTRACT The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) with the European Society of Gynaecological Oncology (ESGO) jointly developed clinically relevant and evidence‐based statements on performing ultrasound‐guided biopsies in gynecological oncology.
D. Fischerova +18 more
wiley +1 more source
Implications of apixaban for dental treatments [PDF]
, 2016 Anticoagulation therapy is used in several conditions to prevent or treat thromboembolism. Recently, new oral anticoagulants have been introduced as alternatives to warfarin and acenocoumarol.
Albaladejo Martínez, Alberto +1 more
core +1 more source
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance [PDF]
, 2013 Nancy El-Helou, Amal Al-Hajje, Rola Ajrouche, Sanaa Awada, Samar Rachidi, Salam Zein, Pascale SalamehClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Beirut, LebanonBackground: Adverse drug events (ADE) occur ...
Ajrouche R +6 more
core +1 more source
The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts [PDF]
, 1991 Stent implantation in native coronary arteries may be complicated by acute thrombosis, despite the use of stringent anticoagulation. Thrombotic occlusion of stented venous grafts may occur less frequently, possibly because of the larger caliber of these ...
Beatt, K.J. (Kevin) +6 more
core +2 more sources
Dabigatran and rivaroxaban, new oral anticoagulants. New approaches in Dentistry [PDF]
, 2010 Treatment in patients with atrial fibrillation or venous thromboembolism in recent decades has been based almost exclusively on the use of vitamin K antagonists.
Aguilar Salvatierra, Antonio +7 more
core +1 more source
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation [PDF]
, 2016 INTRODUCTION: Economic evaluations are becoming increasingly important due to limitations in economic resources, the expense of many new treatments, the need to allocate health spending as effectively as possible, and the need to inform decision makers ...
Carme Pinyol +6 more
core +1 more source
Managing patients taking edoxaban in dentistry [PDF]
, 2017 Anticoagulation therapy is used in several conditions to prevent or treat thromboembolism. A new group of oral anticoagulants with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent ...
Curto Aguilera, Adrián +2 more
core +1 more source
Romanian Journal of CardiologyThe direct oral anticoagulants (DOACS) such as dabigatran (D), rivaroxaban (R), apixaban (A), and edoxaban (E) have become the leading anticoagulation strategy in atrial fibrillation (AF).
Musat Dan L +8 more
doaj +1 more source
Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far
Hematology Reports, 2011 Pulmonary arterial hypertension is an infrequent but nevertheless serious life-threatening severe complication of HIV infection. It can be treated with bosentan and oral anticoagulants.
José Antonio Morales-Molina +3 more
doaj +1 more source
Reacciones adversas a fármacos : nivel de conocimiento [PDF]
, 2018 Las reacciones adversas a fármacos (RAF) pueden afectar gravemente la salud y son motivo de consulta frecuente. Incluso pueden pasar desapercibidas si no se las piensa. Evaluar el conocimiento y valor que el equipo de salud otorga al tema, es fundamental
Anci, Cynthia +5 more
core